Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucie Giraud

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Langmuir : the ACS Journal of Surfaces and Colloids|March 16, 2017
Lubrication with Soft and Hard Two-Dimensional Colloidal ArraysLucie Giraud, Gwénaëlle Bazin, Suzanne Giasson
Biomaterials|November 9, 2016
Single stranded siRNA complexation through non-electrostatic interactionsLucie Giraud, Warren Viricel, Jeanne Leblond, et al.
Cancer Research|December 9, 2024
Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine SynthesisDavid Allard, Jeanne Cormery, Salma Bricha, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapySamya Aouad, Maleck Kadiri, David Allard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Langmuir : the ACS Journal of Surfaces and Colloids|March 16, 2017
Lubrication with Soft and Hard Two-Dimensional Colloidal ArraysLucie Giraud, Gwénaëlle Bazin, Suzanne Giasson
Biomaterials|November 9, 2016
Single stranded siRNA complexation through non-electrostatic interactionsLucie Giraud, Warren Viricel, Jeanne Leblond, et al.
Cancer Research|December 9, 2024
Adenosine Uptake through the Nucleoside Transporter ENT1 Suppresses Antitumor Immunity and T-cell Pyrimidine SynthesisDavid Allard, Jeanne Cormery, Salma Bricha, et al.
Journal for Immunotherapy of Cancer|April 3, 2026
Targeting PAR-2 with a negative allosteric modulator increases tumor antigen presentation and potentiates anti-PD-1 immunotherapySamya Aouad, Maleck Kadiri, David Allard, et al.
Pageof 1